Welcome to our dedicated page for Lake Shore Bncop SEC filings (Ticker: LSBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lake Shore Bancorp, Inc. filings document the company's public-company disclosures as the Maryland holding company for Lake Shore Bank. Current reports record quarterly and annual financial results, cash dividend declarations, share repurchase authorization disclosures, and material agreements affecting governance and board composition.
Proxy materials cover annual meeting matters, director elections, executive compensation and shareholder voting procedures. The filing record also reflects the company's capital structure and corporate-status history following the completed mutual-to-stock conversion and the Bank's conversion to a New York chartered commercial bank.
Lake Shore Bancorp, Inc. director Dennis Pollack filed an initial statement of beneficial ownership of securities. The filing shows that, as of the reported date, he held no shares of the company’s common stock directly, with zero shares listed as owned following the reported entry.
Lake Shore Bancorp director Ronald J. Passafaro reported a stock award of 573 shares of common stock. The shares were granted at no cost as restricted stock and will vest on March 18, 2027. After this grant, he directly holds 45,837 common shares, which include the unvested restricted stock, and indirectly holds 2,438 shares through an IRA. He also has stock options exercisable for 10,749 common shares at an exercise price of $14.85 per share, expiring on December 9, 2035, with vesting scheduled at 20% per year starting December 9, 2026. This filing reflects routine equity compensation rather than an open-market purchase or sale.
Gilden Taylor M reported acquisition or exercise transactions in this Form 4 filing.
Lake Shore Bancorp, Inc. CFO and Treasurer Taylor M. Gilden received a grant of 3,028 shares of restricted common stock on March 18, 2026 as compensation, at no cash cost per share. These restricted shares vest in four equal annual installments beginning on March 18, 2027.
After this grant, Gilden directly holds 22,403 common shares, which include earlier unvested restricted stock awards referenced in the footnotes. In addition, 2,522 shares are held indirectly through an IRA and 372 shares are held indirectly through an Employee Stock Ownership Plan allocation.
LIDDELL KIM C reported acquisition or exercise transactions in this Form 4 filing.
Lake Shore Bancorp reported that Kim C. Liddell, Dir., President and CEO of the bank, received a grant of 6,285 shares of restricted common stock on March 18, 2026 at a stated price of $0.00 per share as compensation. These restricted shares vest in four equal annual installments beginning on March 18, 2027. Following the grant, Liddell holds 70,998 common shares directly, which include earlier unvested restricted stock awards, and also has indirect ownership of additional shares through a spouse, an IRA, and an ESOP allocation.
Lake Shore Bancorp, Inc. executive vice president Jeffrey M. Werdein reported an equity compensation grant of 3,025 shares of Common Stock on March 18, 2026. These shares are unvested restricted stock that were granted at no cash cost and vest in four equal annual installments beginning on the first anniversary of the grant.
After this award, Werdein directly holds 54,557 Common shares and has a fully vested stock option covering 23,132 shares of Common Stock with a $10.62 exercise price, expiring on October 21, 2026. He also reports additional indirect Common Stock holdings through an IRA, an employee stock ownership plan allocation, and family accounts, which reflect ownership structure rather than new transactions.
Lake Shore Bancorp director Sharon E. Brautigam received an equity grant of 527 shares of common stock on March 18, 2026. The shares are restricted stock that vest on March 18, 2027, so she does not receive them outright until that date.
After this grant, she holds 23,814 common shares directly, which include 893 unvested restricted shares scheduled to vest on December 9, 2026 and the 527 unvested shares vesting on March 18, 2027. She also has indirect holdings of 474 shares held by her spouse and 20,000 shares held by an IRA.
In addition, she holds stock options covering 2,570 shares of common stock at an exercise price of $7.89 per share, expiring on April 22, 2034. Of these options, 514 are vested and exercisable and 2,056 remain unvested, scheduled to vest in equal annual installments beginning one year after the April 23, 2024 grant date.
Lake Shore Bancorp director John L. Mehltretter reported receiving a grant of 667 shares of restricted Common Stock at no cash cost. These shares vest on March 18, 2027. Following the grant, he holds 19,600 Common shares directly and 20,000 shares indirectly through an IRA.
He also holds stock options over 5,237 Common shares with a $14.85 exercise price expiring on December 9, 2035, which vest 20% per year beginning on December 9, 2026, and options over 7,468 shares at $7.89 expiring on April 22, 2034, of which 5,975 are unvested and 1,493 are vested and exercisable.
Lake Shore Bancorp, Inc. director John P. McGrath received an equity grant of 589 shares of common stock as compensation. The shares are restricted stock that will vest on March 18, 2027, meaning he must wait until that date for them to fully become his.
After this award, McGrath holds 10,873 common shares directly, which include the 589 unvested restricted shares, and 79,927 additional shares indirectly through an IRA. He also holds stock options covering 8,220 common shares at an exercise price of $14.85 per share, vesting 20% per year starting December 9, 2026 and expiring in 2035.
Lake Shore Bancorp, Inc. director Kevin M. Sanvidge received an equity award of 893 shares of Common Stock as a grant at no cash cost on March 18, 2026. Following this award, he directly holds 57,324 common shares, which include unvested restricted stock scheduled to vest on December 9, 2026 and March 18, 2027.
He also holds stock options covering 14,563 common shares at an exercise price of 10.6200 per share that are fully vested and expire on October 21, 2026, and options covering 2,570 shares at 7.8900 per share expiring on April 22, 2034, of which 514 are currently vested and exercisable and 2,056 remain unvested. In addition, 3,150 common shares are held indirectly as custodian for his grandchildren.